Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.

Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.

Dengue virus (DENV) is a major public health threat worldwide. A key element in protection from dengue fever is the neutralising antibody response. Anti-dengue IgG purified from DENV-2 infected human sera showed reactivity against several peptides when evaluated by ELISA and epitope extraction techn...

Full description

Bibliographic Details
Main Authors:	Babu Ramanathan, Chit Laa Poh, Kristin Kirk, William John Hannan McBride, John Aaskov, Lara Grollo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4880327?pdf=render

Similar Items

Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles
by: Yanqi Chan, et al.
Published: (2020-07-01)

Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
by: Mohd Ishtiaq Anasir, et al.
Published: (2020-03-01)

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
by: Leike Li, et al.
Published: (2019-06-01)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, et al.
Published: (2019-03-01)

Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
by: Guohua Yi, et al.
Published: (2013-01-01)

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
by: Kevin O. Saunders, et al.
Published: (2017-02-01)

Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines
by: Josilene Ramos Pinheiro, et al.
Published: (2021-08-01)

Role of microRNAs in antiviral responses to dengue infection
by: Rui Rui Wong, et al.
Published: (2020-01-01)

Correction: Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses.
by: Guohua Yi, et al.
Published: (2013-01-01)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Hui Xuan Lim, et al.
Published: (2021-03-01)

Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
by: Wen-Fan Shen, et al.
Published: (2018-10-01)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
by: Emily N Gallichotte, et al.
Published: (2018-02-01)

Roles of dengue NS1-elicited immunoglobulin in the survival and the neutralizing antibody production of B lymphocytes
by: Chung-Lin Tsai, et al.

Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes.
by: Nicasio Mancini, et al.
Published: (2009-12-01)

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein
by: Denicar Lina Nascimento Fabris Maeda, et al.
Published: (2017-09-01)

Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
by: Eric K Dumas, et al.
Published: (2020-01-01)

Correction: Lalani, S. and Poh, C.L<i>.</i> Flavonoids as Antiviral Agents for <i>Enterovirus A71</i> (<i>EV-A71</i>). <i>V</i>iruses 2020, <i>12</i>, 184
by: Salima Lalani, et al.
Published: (2020-06-01)

Flavonoids as Antiviral Agents for <i>Enterovirus A71</i> (<i>EV</i>-<i>A71</i>)
by: Salima Lalani, et al.
Published: (2020-02-01)

The potently neutralizing monoclonal antibody 1B7 : its unique epitope, effects on intracellular trafficking, and elicitation upon infection with pertussis
by: Sutherland, Jamie Nicole
Published: (2010)

Study of the epitopes on dengue virus envelop protein recognized by different antibodies and the relationship to neutralization potency, specificity and maturation status
by: Hong-En Lin, et al.
Published: (2013)

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
by: Ema T Crooks, et al.
Published: (2015-05-01)

Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand
by: Sararat Hattakam, et al.
Published: (2021-05-01)

Recent advances in delivery of veterinary DNA vaccines against avian pathogens
by: Seyed Davoud Jazayeri, et al.
Published: (2019-10-01)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
by: Seyed Davoud Jazayeri, et al.
Published: (2019-11-01)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Hui Xuan Lim, et al.
Published: (2019-11-01)

Structural Vaccinology for Viral Vaccine Design
by: Mohd Ishtiaq Anasir, et al.
Published: (2019-04-01)

Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence
by: Madiiha Bibi Mandary, et al.
Published: (2018-06-01)

Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs
by: Giselle Rangel, et al.
Published: (2021-05-01)

Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice
by: Milan Kuchař, et al.
Published: (2021-01-01)

Fitness peaks of dengue virus populations.
by: Wen Jun Liu, et al.
Published: (2018-01-01)

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
by: Laura A VanBlargan, et al.
Published: (2013-01-01)

Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III.
by: Guang-Hui Ji, et al.
Published: (2015-01-01)

Administration of Defective Virus Inhibits Dengue Transmission into Mosquitoes
by: Tarunendu Mapder, et al.
Published: (2020-05-01)

Development of Novel Vaccines against Enterovirus-71
by: Pinn Tsin Isabel Yee, et al.
Published: (2015-12-01)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01)

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
by: Andrew L Ferguson, et al.
Published: (2013-01-01)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
by: Ferguson, Andrew L., et al.
Published: (2014)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies
by: Olga V. Chervyakova, et al.
Published: (2016-06-01)

Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
by: Sidhartha Chaudhury, et al.
Published: (2017-02-01)

Cannot write session to /tmp/vufind_sessions/sess_qoib400fhomc8o5t5hdq5nkd8s